Condition: Exercise · Blood Pressure · Vasodilation · Sponsor: Nuritas Ltd
Examining the safety and tolerability of Lentil Protein Hydrolysate in healthy males and females whilst exploring the effects of a dose range on blood pressure control and vascular function and exercise performance
This description comes directly from the study's public registry record.
Niamh M Mohan, PhD · +353 1 430 1290 · mohan.niamh@nuritas.com
Brian Keogh, Phd · +353 1 430 1290
Always discuss trial participation with your own doctor first.
| Baker Heart and Diabetes Institute | Melbourne, Victoria, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06894875